Document Detail


Comparison of In-Hospital Mortality From Acute Myocardial Infarction in HIV Sero-Positive Versus Sero-Negative Individuals.
MedLine Citation:
PMID:  22762716     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Few studies have explored hospitalization outcome differences between patients who are seropositive for human immunodeficiency virus (HIV) compared to HIV-seronegative patients with acute myocardial infarctions (AMIs). The aim of this study was to explore in-hospital AMI mortality risk in seropositive and seronegative patients. A secondary analysis of the Nationwide Inpatient Sample from 1997 to 2006 was conducted. This sample allows the approximation of all United States hospitalizations. All AMI encounters with and without co-occurring HIV were identified using appropriate International Classification of Diseases and procedure codes. Descriptive and Cox proportional-hazards analyses were then conducted to estimate mortality differences between seropositive and seronegative patients while adjusting for demographic, clinical, hospital, and care factors. The results demonstrated higher AMI hospitalization mortality hazard in seropositive compared to seronegative patients after adjustment for age, gender, ethnicity, medical co-morbidities, hospital type, and number of in-hospital procedures (HR 1.38, 95% confidence interval 1.01 to 1.87, p = 0.04). Stratified analysis demonstrated greater although not statistically significant mortality hazard for non-ST-segment elevation myocardial infarction and ST-segment elevation myocardial infarction in seropositive compared to seronegative patients. Typical AMI care procedures occurred at significantly lower rates in seropositive versus seronegative patients, including thrombolytic and anticoagulant agents (18% vs 22%), coronary arteriography (48% vs 63%), left cardiac catheterization (52% vs 66%), and coronary artery bypass graft (6% vs 14%). In conclusion, additional mortality burden and lower procedure rates occur for HIV-seropositive patients receiving AMI care. Health care providers should be alert to the increased mortality burden when treating seropositive patients with AMI.
Authors:
Daniel Pearce; Chizobam Ani; Yaminah Espinosa-Silva; Ryan Clark; Khuteja Fatima; Munira Rahman; Erik Diebolt; Bruce Ovbiagele
Related Documents :
12486986 - Secondary prevention following myocardial infarction: evidence from an audit in south w...
21551276 - Development of a preclinical model of ischemic cardiomyopathy in swine.
22040936 - Three-year follow-up of sirolimus-eluting stents vs. bare metal stents for acute myocar...
2897296 - Beta-adrenoceptor blocking drugs in primary and secondary prevention of myocardial infa...
22593266 - Heart-type fatty acid binding protein as an early marker for myocardial infarction: sys...
16084166 - The impact of acute coronary syndrome on clinical, economic, and cardiac-specific healt...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-7-2
Journal Detail:
Title:  The American journal of cardiology     Volume:  -     ISSN:  1879-1913     ISO Abbreviation:  -     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-7-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Inc. All rights reserved.
Affiliation:
Department of Internal Medicine, Loma Linda University, Loma Linda, California.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical Features and Outcomes of Cardiovascular Implantable Electronic Device Infections Due to Sta...
Next Document:  Incremental Value of Late Gadolinium Enhancement for Management of Patients With Hypertrophic Cardio...